cACLD in Patients With Alcohol Use Disorder in the Hospital Detoxification Unit

Enrolling by invitationOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

March 6, 2024

Primary Completion Date

March 12, 2024

Study Completion Date

December 31, 2026

Conditions
Liver Disease ChronicCirrhosisDetoxificationAlcohol Abuse/Dependence
Interventions
DIAGNOSTIC_TEST

Screening of compensated advance chronic liver disease

"The tests performed will include a general blood analysis to evaluate liver and kidney function, an assessment of the prevalence of metabolic diseases such as obesity, hypertension, or diabetes, an abdominal ultrasound, and elastography to assess liver stiffness.~Another intervention to be studied is whether the request for diagnostic tests to evaluate liver disease, as well as the visit of the hepatologist during hospitalization in the detoxification unit, influences subsequent alcohol abstinence. To this end, abstinence will be assessed six months after admission to the alcohol detoxification unit and compared with a retrospective cohort of patients admitted to the detoxification unit one year ago, in whom no liver disease evaluation was conducted neither information of potencial liver damage was offered by hepatologist and the intervention was carried out only by the psychiatrists responsible for the unit."

Trial Locations (1)

08208

Consorci Corporació Sanitària Parc Taulí, Sabadell

Sponsors
All Listed Sponsors
lead

Corporacion Parc Tauli

OTHER